Entity

Time filter

Source Type

Zhengzhou, China

Fan X.H.,Anorectal Branch
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban | Year: 2013

To develop quality of life questionnaire of Chinese medicine for postoperative patients with colorectal cancer (QLQ-CMPPCC), thus comprehensively and objectively evaluating the clinical efficacy of Chinese medicine and pharmacy in treating postoperative patients with colorectal cancer (CC). The theoretical structure model of the questionnaire was addressed in combined with basic theories of Chinese medicine according to the principle of WHO quality of life (QOL). The primary questionnaire was developed using methods of structuralization policy making after we extensively retrieve various universal and specific questionnaires for CC cancer patients at home and abroad. The 205 CC patients were tested by questionnaire. The items were screened using experts grading method, item selection analysis, dispersion trends of standard deviation, t-test, correlation coefficient method, factor analysis,and Cronbach's alpha. The QLQ-CMPPCC was developed containing four domains of physical, psychological, independence, and social functions, involving 20 aspects and 54 items. Of them, non-fistula patients answered 43 items and fistula patients answered 46 items. One item covered the general QOL evaluation. QLQ-CMPPCC showed Chinese medical features. It comprehensively reflected the connotation of QOL for postoperative CC patients. It could be taken as a tool for evaluating Chinese medical efficacy for postoperative CC patients. Source


Cai S.-D.,Anorectal Branch | Chen J.-S.,Center for Reproductive Medicine | Xi Z.-W.,Anorectal Branch | Zhang L.-J.,Anorectal Branch | And 2 more authors.
Molecular Medicine Reports | Year: 2015

Cancer of the colon and rectum are two distinct entities, which require different treatment strategies and separate treatment. MicroRNAs (miRNAs) act as critical regulators of genes involved in several biological processes. Aberrant alterations of miRNAs have been found in several types of cancer, including colon cancer and rectal cancer. Extensive catalogues of downregulated miRNAs have been identified for colon cancer, whereas only limited data are available for rectal cancer. An example of miRNA profiling in a previous study found that miRNA (miR)-144 showed aberrant expression and appeared to be rectal cancer-specific, its expression not being reported in colon cancer. In the present study, the role of miR-144 in rectal cancer was investigated. SW837 and SW1463 cell lines were selected as rectal cell carcinoma cells. Using reverse transcription-quantitative polymerase chain reaction, western blot, BrdU, cell migration and cell viability assays, it was found that the expression levels of miR-144 were significantly reduced in the SW837 and SW1463 cell lines, and the overexpression of miR-144 suppressed rectal cancer cell viability, migration and proliferation. In addition, Rho-associated coiled-coil containing protein kinase 1 (ROCK1) was identified as a target of miR-144 in the rectal cancer cells. The supplementation of ROCK1 markedly restored the cell migration and proliferation, which was inhibited by miR-144. Together, the data of the present study demonstrated that miR-144 acts as a tumor suppressor by targeting ROCK1, and indicates the potential of miR-144 as a novel biomarker and target in the treatment of rectal cancer. Source

Discover hidden collaborations